ASCACID 10% 1 L // Albendazole // for cattle / per bovini

DECLARATION OF ACTIVE SUBSTANCES AND OTHER INGREDIENTS

100 ml of suspension contain:

Albendazole (methyl-5N-propylthio-2-benzimidazole carbamate) 10 g
Excipients: monopropylene glycol, sodium carboxymethylcellulose, sodium benzoate, demineralized water

INDICATIONS
The product is indicated in cattle in the treatment of gastrointestinal and pulmonary nematodes (Ostertagia spp., Nematodirus spp., Haemonchus spp., Trichostongylus spp., Cooperia spp., Dictyocaulus spp., Bunostomum spp., Oesophagostomum spp.) and trematodes (Fasciola spp. .) and cestodes (Moniesia spp.).

CONTRAINDICATIONS
Due to the potential teratogenic and embryotoxic effect, it should not be administered during the first 45 days of pregnancy.

ADVERSE REACTIONS
The product is well tolerated in therapeutic doses. If you notice severe effects or other effects not mentioned in this leaflet, notify your veterinarian immediately.

TARGET SPECIES
Cattle.

DOSAGE FOR EACH SPECIES, ROUTES AND METHOD OF ADMINISTRATION
ASCACID 10% is administered orally with a syringe or with another graduated device for administering oral suspensions to animals, in a single dose of 10 mg albendazole /kg body weight (10 ml Ascacid 10%/100 kg body weight)
In case of reinfestation, the treatment is repeated after 3 months.
To ensure a correct administration of the therapeutic dose, the body weight of the animal must be determined as precisely as possible.
in the case where several animals are treated at once, they must be grouped according to their weight and the dose adapted accordingly, to avoid under- or overdose.

RECOMMENDATIONS REGARDING THE CORRECT ADMINISTRATION
Shake the bottle before use.

WAITING TIME
Meat and organs: 28 days

Milk: 3 days

STORAGE PRECAUTIONS
Store the product in a dry, dark place, below 25°C, away from frost.

SPECIAL WARNINGS
Special warnings for each target species:
The following practices increase the risk of development of resistance and consequently may determine the ineffectiveness of anthelmintic therapy:
Repeated and too frequent use of anthelmintics of the same class, over an extended period of time
Under-dosing, which can be caused by an underestimation of the animal's body weight or an incorrect administration of the product.
Suspected clinical cases of resistance to anthelmintics should be investigated using paraclinical tests, eg the total egg count reduction test. In the event that the tests indicate resistance to a certain class of anthelmintics, an anthelmintic with a different mode of action must be resorted to by changing the class.
Resistance to albendazole has been reported on Fasciola hepatica, Trichostrongylus spp, Haemonchus spp and Oesophagostomum spp. Therefore, the use of this product must be supported by local epidemiological information (regional, farm level) about the susceptibility of Fasciola hepatica, Trichostrongylus spp, Haemonchus spp and Oesophagostomum spp and accompanied by recommendations about ways to limit the selection of resistance to albendazole.
Use during pregnancy, lactation
Due to the potential teratogenic and embryotoxic effect, it should not be administered during the first month of pregnancy.
Interactions with other medicinal products or other forms of interaction
It is not associated with cimetidine and praziquantel which decrease the absorption of albendazole by changing the Ph in the rumen.
Overdose (symptoms, emergency procedures, antidotes), as the case may
be Exceeding the dose by up to 20 times does not cause adverse reactions.

SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE, AS APPLICABLE.
Treated animals will be kept in isolated spaces and droppings will not be used to fertilize the soil.
Any unused veterinary medicinal product or waste from the use of such products must be disposed of in accordance with local requirements.